Undisclosed ADC Program(s)

About Zenobia Therapeutics

Zenobia Therapeutics is a private, preclinical-stage biotech developing next-generation antibody-drug conjugates (ADCs) for solid tumors. The company is leveraging a novel payload technology platform designed to overcome common limitations of existing ADCs, such as tumor resistance and systemic toxicity. Operating in the high-growth oncology sector, Zenobia aims to advance its pipeline into clinical development, positioning itself as an attractive partner or acquisition target for larger pharmaceutical companies. Its success hinges on the preclinical validation of its platform and its ability to secure future funding to reach key clinical milestones.

About MediaPharma

MediaPharma is a private, preclinical-stage biotechnology company specializing in the development of novel monoclonal antibody-based therapeutics, primarily Antibody-Drug Conjugates (ADCs), for oncology and severe diseases. The company leverages an interdisciplinary team and leading-edge preclinical technologies to design ADCs that selectively target diseased cells while aiming to minimize off-target effects. Operating in an advanced preclinical stage, MediaPharma's strategy is centered on translating its research into concrete therapies for conditions lacking adequate treatment options. Its focus remains on rigorous preclinical validation of efficacy and safety to build a compelling case for future clinical development and partnership.

About Levena Biopharma

Levena Biopharma is a private, preclinical-stage biotech developing next-generation antibody-drug conjugates (ADCs) for oncology. The company's platform is centered on engineering ADCs with optimized components—including antibodies, linkers, and payloads—to achieve a superior therapeutic index. As a pre-revenue entity, it is likely funded by venture capital and is advancing its pipeline toward clinical development. Its success hinges on demonstrating the superiority of its ADC constructs in treating cancers with high unmet need.

Therapeutic Areas

Other Solid Tumors Drugs